Literature DB >> 24134168

Functional bowel symptoms and diet.

P R Gibson1, J S Barrett, J G Muir.   

Abstract

It is well recognised that ingestion of food is a trigger for functional bowel symptoms, particularly those associated with irritable bowel syndrome (IBS). Patients often use manipulation of diet as a means of controlling symptoms. Despite description of multiple dietary methods, few have scientific backing or quality evidence of efficacy. One approach is to define how specific food components influence the pathophysiology of IBS and then rationally design dietary approaches. For example, short-chain poorly absorbed carbohydrates (fermentable oligo-, di- and mono-saccharides and polyols (FODMAP)) cause luminal distension, which is a major stimulus for the development of symptoms in patients with visceral hypersensitivity. By determining food content of FODMAP, a diet in which foods low in FODMAP are favoured over those high in FODMAP can be designed. Observational, comparative and randomised controlled treatment and rechallenge studies have shown that such an approach is efficacious in the majority of patients with IBS. The low FODMAP diet is now the primary dietary therapy for such patients. Similar approaches can be applied to other food components, including proteins (such as gluten), fats and natural bioactive food chemicals. Such approaches have suggestions of efficacy, but the evidence base remains underdeveloped. An additional and important consideration for any dietary therapy is its nutritional adequacy and potential adverse health effects. Dietary manipulation is now a key management strategy in patients with functional bowel symptoms. Future well-designed interventional studies will lead to refinement of dietary approaches taken and to a better understanding of their long-term safety.
© 2013 The Authors; Internal Medicine Journal © 2013 Royal Australasian College of Physicians.

Entities:  

Keywords:  carbohydrate; diet; fat; food chemical; irritable bowel syndrome; protein

Mesh:

Substances:

Year:  2013        PMID: 24134168     DOI: 10.1111/imj.12266

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  7 in total

1.  Colonic Fermentation of Unavailable Carbohydrates from Unripe Banana and its Influence over Glycemic Control.

Authors:  Milana C T Dan; Giselli H L Cardenette; Fabiana A H Sardá; Eliana Bistriche Giuntini; Luis Arturo Bello-Pérez; Ângelo R Carpinelli; Franco M Lajolo; Elizabete Wenzel Menezes
Journal:  Plant Foods Hum Nutr       Date:  2015-09       Impact factor: 3.921

2.  Ehealth: low FODMAP diet vs Lactobacillus rhamnosus GG in irritable bowel syndrome.

Authors:  Natalia Pedersen; Nynne Nyboe Andersen; Zsuzsanna Végh; Lisbeth Jensen; Dorit Vedel Ankersen; Maria Felding; Mette Hestetun Simonsen; Johan Burisch; Pia Munkholm
Journal:  World J Gastroenterol       Date:  2014-11-21       Impact factor: 5.742

3.  The Effect of the Low FODMAP Diet on Gastrointestinal Symptoms, Behavioral Problems and Nutrient Intake in Children with Autism Spectrum Disorder: A Randomized Controlled Pilot Trial.

Authors:  Nalan Hakime Nogay; Jennifer Walton; Kristen M Roberts; Marcia Nahikian-Nelms; Andrea N Witwer
Journal:  J Autism Dev Disord       Date:  2021-08

4.  Functional Gastrointestinal Disorders and the Microbiome-What Is the Best Strategy for Moving Microbiome-based Therapies for Functional Gastrointestinal Disorders into the Clinic?

Authors:  Ruben A T Mars; Mary Frith; Purna C Kashyap
Journal:  Gastroenterology       Date:  2020-11-28       Impact factor: 22.682

5.  Changes in small intestinal chromogranin A-immunoreactive cell densities in patients with irritable bowel syndrome after receiving dietary guidance.

Authors:  Tarek Mazzawi; Magdy El-Salhy
Journal:  Int J Mol Med       Date:  2016-03-11       Impact factor: 4.101

Review 6.  Effect of diet and individual dietary guidance on gastrointestinal endocrine cells in patients with irritable bowel syndrome (Review).

Authors:  Tarek Mazzawi; Magdy El-Salhy
Journal:  Int J Mol Med       Date:  2017-08-11       Impact factor: 4.101

7.  Chain length of dietary fatty acids determines gastrointestinal motility and visceromotor function in mice in a fatty acid binding protein 4-dependent manner.

Authors:  Paula Mosińska; Adrian Szczepaniak; Tatiana Wojciechowicz; Marek Skrzypski; Krzysztof Nowak; Jakub Fichna
Journal:  Eur J Nutr       Date:  2019-09-27       Impact factor: 5.614

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.